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a EgyptBackground: Dobutamine stress echocardiography (DSE) is widely used for detection of myocardial viability. The
main limitation of DSE is its subjective interpretation. Assessment of mitral annular motion velocities with tissue
Doppler imaging is a simple and quantitative measurement.
Objective: To determine the relationship between myocardial viability and regional systolic mitral annular
motion tissue Doppler velocities responses to dobutamine stress.
Methods: Our study group included 42 patients with previous myocardial infarction referred for coronary
angiography and revascularization. We did dobutamine stress tissue Doppler echocardiography (DSTDE) measur-
ing velocities of pre-ejection wave (pre-Ej) and peak ejection wave (Ej) at rest and during low-dose dobutamine
infusion. We did follow up echocardiography after 1 month.
Results: After exclusion of the normokinetic walls, we analyzed 196 walls. Using receiver operator characteristic
ROC curves, the optimal cut-off value for viability assessment was an increase of 1.75 cm/s in pre-ejection velocity
during DSTDE (area under the curve 0.70, p < 0.001). On the other hand, the optimal cut-off value for viability assess-
ment was an increase of 1.75 cm/s in ejection velocity during DSTDE (area under the curve 0.613, p = 0.01). The
sensitivity, specificity, and total accuracy of the DSTSE (pre-Ej) versus the gold standard for detection of myocardial
viability were 66.15%, 67.94%, and 67.35%, respectively. The sensitivity, specificity, and total accuracy of the DTSE
(Ej) were 56.92%, 64.12%, and 61.43%, respectively. There was a good correlation between the pre-Ej at 5 ug/kg/min
dobutamine infusion and the pre-Ej after revascularization (r = 0.64, p = 0.01) while the correlation with the Ej was
moderate (r = 0.50, p = 0.01).
Conclusion: Viable left ventricular myocardium could be identified easily and quantitatively with pre-ejection
mitral annular velocity during dobutamine infusion. The pre-ejection wave during DSTDE showed greater sensitiv-
ity and specificity for the prediction of myocardial viability than the ejection wave.
 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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Abbreviations
+Vic myocardial positive pre-ejection velocity
CABG Gcoronary artery bypass grafting
CI 95% confidence interval
DSE Dobutamine stress echocardiography




IVS interventricular septal thickening
LA left atrial diameter
LAD left anterior descending
LCX left circumflex
LDDSE low dose dobutamine stress echocardiography
LV left ventricular
LVEDD left ventricular end diastolic diameter
LVEF left ventricular ejection fraction
LVESD left ventricular end systolic diameter
MI myocardial infarction
MRI magnetic resonance imaging
PCI percutaneous coronary intervention
PET positron emission tomography
pre-Ej pre-ejection wave
PW posterior wall thickening
RCA right coronary artery
ROC receiver operator characteristic
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Assessment of myocardial viability in patientswith myocardial infarction is important.
Myocardial scintigraphy [1], dobutamine stress
echocardiography, [2] and contrast echocardiogra-
phy [3] are used in the determination of viability.
Among these procedures, dobutamine stress
echocardiography is widely used in the clinical
setting because it is a safe and accurate method
for detection of myocardial viability. The main
limitation of dobutamine echocardiography is its
subjective interpretation [4].
Because the mitral annulus shifts towards the
cardiac apex during systole [5], the mitral annular
motion recorded with M-mode echocardiography
correlates with the left ventricular ejection fraction
[6,7] and myocardial viability [8]. One study
showed that changes in the amplitude of the AV
plane displacement during low-dose dobutamine
stress echocardiography can easily be used to
detect myocardial viability at an early stage with
late potential for spontaneous recovery [9].
Tissue Doppler imaging facilitates the direct
measurement of the left ventricular wall and mi-
tral annular motion velocities [10,11]. This method
can therefore be used for quantitation of regional
left ventricular wall motion [12]. Thus, the param-
eters obtained from mitral annular systolic motion
velocities with pulsed tissue Doppler imaging
reflect left ventricular (LV) asynergy correspond-
ing to the infarct regions in patients with myocar-
dial infarction, and global LV systolic function
may be evaluated with these parameters [13].
Assessment of mitral annular motion velocities
along the long axis with tissue Doppler imaging
has several advantages over other methods, such
as the simplicity of measurement, superior time
resolution, and preload independence [13–15].
However, there have been no many studies
correlating myocardial viability and regional
systolic mitral annular motion velocity response
to dobutamine stress, particularly during early
systole. It has been found that the pre-systolic
annular motion towards the cardiac apex
accurately predicts regional left ventricular myo-
cardial viability [12].Objective
The objective of this study is to determine
the accuracy of regional systolic mitral annular
motion tissue Doppler velocities responses to
dobutamine stress in the detection of myocardial
viability in patients with previous myocardial
infarction.Methodology
We enrolled consecutive patients with previous
myocardial infarction who were referred to Ain
Shams University Hospitals for coronary angiog-
raphy and revascularization.
Inclusion criteria were: (1) Significant (>50%)
reduction in the luminal diameter of a major
coronary artery corresponding to the infarcted
area on the basis of recent coronary angiographic
results; (2) previous Q-wave myocardial infarction
of more than one-week duration; and (3) regional
left ventricular wall motion abnormality corre-
sponding to the infracted region on the basis of
two-dimensional echocardiography. The infract-
related coronary artery stenosis was revascular-
ized by either coronary artery bypass grafting
(CABG) or percutaneous coronary intervention
(PCI).
Exclusion criteria were: (1) Postinfarction unsta-
ble angina or infarction complicated by severe
hemodynamic instability; (2) decompensated con-
gestive heart failure; (3) protruding thrombus in
the left ventricular cavity with fresh mobile edges;
(4) significant valvular or congenital heart disease;
(5) any myocardial disease apart from ischemia;
(6) coexistent relevant liver or renal disease; (7) a
contraindication to dobutamine administration
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graphic imaging.
The study was approved by the medical ethics
committee of our institution. The study protocol
was designed in accordance with The Code of
Ethics of the World Medical Association (Declara-
tion of Helsinki) for experiments involving
humans. All patients gave informed consent be-
fore the procedure.
Baseline transthoracic echocardiographic exam-
ination: Images were acquired with the patient
in the left lateral decubitus position using a multi-
frequency phased array transducer of 2.5–3.5 MHz
attached to Vivid V echocardiography machine
(General Electric medical systems, manufactured
in Horten, Norway) equipped with Doppler tissue
imaging (DTI) technology. We measured the left
ventricular end diastolic diameter (LVEDD), left
ventricular end systolic diameter (LVESD), left at-
rial diameter (LA), Ejection fraction (EF), resting
segmental wall motion. The left ventricle was
divided into the standard 16-segment model rec-
ommended by the American Society of Echocardi-
ography [16]
We graded each myocardial segment using the
following semi-quantitative scoring system: Nor-
mal contraction was defined as 5 mm endocardial
excursion, 25% systolic thickening, and assigned a
score of 1. Hypokinesia was defined as <5 mm
endocardial excursion, <25% systolic thickening,
and assigned a score of 2. Akinesia was defined
as virtual absence of systolic myocardial thicken-
ing, even if slight inward motion was present dur-
ing systole, and assigned a score of 3. Dyskinesia
was defined as paradoxical endocardial excursion
away from the left ventricular lumen in systole,
and assigned a score of 4.
Aneurysm was defined as continuous distortion
of the wall both in systole and diastole, and
assigned a score of 5. Aneurysm with scar was
defined as score 5 + scar of previous MI. It was as-
signed a score of 6.Dobutamine stress tissue Doppler
echocardiography (DSTDE)
We infused dobutamine in a stepwise manner
(0, 5 and 10 ug/kg/min) during 3 min intervals.
At each dose, heart rate and blood pressure were
measured. We calculated left ventricular ejection
(LVEF) fraction at rest and at the end of each
infusion stage of the pharmacologic stress
protocol.
DSTDE was done for studying the systolic mitral
annular motion velocities at six mitral annular
sites that reflect the asynergy at these sites corre-sponding to the infarct regions in patients with
myocardial infarction: (anteroseptal and posterior
walls in the apical long axis view, posteroseptal
and lateral walls in the apical 4-chamber view,
and anterior and inferior walls in the apical 2-
chamber view). The acoustic power and filter fre-
quencies of the ultrasound scan system were set
to the lowest values possible, and the sample col-
umns (width of approximately 8 mm) were set at
the mitral annulus. The peak velocity was deter-
mined as the average peak velocity from three
consecutive beats, both in the pre-ejection phase
and during left ventricular contraction in the ejec-
tion period. Briefly, to define the pre-ejection per-
iod, aortic flow was recorded by pulsed-wave
Doppler at the level of LV outflow tract at the
beginning and at the end of each examination.
Pre-ejection was defined as a time interval be-
tween the onset of QRS complex and the onset
of aortic flow. Cardiac cycles with extrasystolic,
post-extrasystolic beats, or any rhythm distur-
bance were excluded. Recording was repeated
during dobutamine infusion at 0, 5 and 10 ug/kg/
min. Analysis was performed by one observer
(AO). Measurements of theses parameters were
highly reproducible by the same observer for each
patient. Reproducibility (intra-observer variabil-
ity) was assessed by coefficient of variation for re-
peated measures in the first 10 patients.
End points for interrupting any of the above
mentioned infusion protocols were: (1) intolerable
symptoms such as severe headache, severe nau-
sea and vomiting; (2) severe chest pain and/or
dyspnea with evidence of clinical ischemia
defined as P2.0 mm of additional ST segment
depression or elevation in at least two contiguous
leads compared with rest ± new remote wall
motion abnormality or worsening contractility in
previously asynergic segments; (3) limiting
asymptomatic side effects including hypertension
(systolic blood pressure > 220 mmHg and/or dia-
stolic blood pressure > 120 mmHg), hypotension
(relative or absolute i.e. >30 mmHg decrease in
blood pressure), sustained supraventricular
tachyarrhythmia particularly atrial fibrillation,
ventricular arrhythmias (frequent, polymorphous
premature ventricular beats or ventricular tachy-
cardia) and bradyarrhythmias. In the event of
demonstrable ischemia, intravenous beta blockers
and/or nitroglycerin were administered.Follow up
We performed transthoracic two-dimensional
echocardiography at 1 month after revasculariza-
tion to detect improvement in regional wall mo-
Table 1. Baseline clinical and angiographic characteristics of
the study group.
Patients (n = 42)
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TDI study was conducted during follow-up to
detect improvement in the value of the pre-ejec-
tion wave or ejection waves. Improvement after
revascularization (the gold standard of viability)
was considered if there was any improvement by
one or more grades of at least one myocardial seg-








Anterior and inferior 13 (31%)






Single vessel 9 (21.4%)
Double vessel 13 (31%)
Three vessel 20 (47.6%)
Baseline echocardiography
LVEDD in mm 59.8 ± 9.2
LVESD in mm 45.4 ± 9.7
IVS in mm 9.7 ± 1.6
PW in mm 1.3 ± 1.3Statistical analysis
The data were statistically analyzed using the
Statistical Package for Social Sciences (SPSS) soft-
ware version 14. Categorical variables were com-
pared by Chi square test. Continuous normally
distributed variables were compared by Paired-
sample t-test. Pearson correlation was done for
continuous variables. Specificity and sensitivity
of dobutamine mitral annular TDI echo were cal-
culated against the gold standard of viability
(improvement with revascularization). The opti-
mal pre-ejection and ejection velocity changes
for the prediction of myocardial viability
(improvement with revascularization) were deter-
mined by a receiver operator characteristic (ROC)
curve constructed for the pre-ejection and ejection
velocity values. A p value 60.05 (2-tailed) was con-
sidered significant and a p value 60.01 was con-
sidered highly significant.LVEF 38.2 ± 9.5
LAD in mm 39.4 ± 7.1
MI = myocardial infarction, LAD = left anterior descending, LCX = left
circumflex, RCA = right coronary artery, LVEDD = left ventricular end
diastolic diameter, LVESD = left ventricular end systolic diameter,
IVS = interventricular septal thickening, PW = posterior wall thicken-
ing, LVEF = left ventricular ejection fraction, LAD = left atrial diameter.
Data are expressed as a mean ± standard deviation or a number
(percent).
Table 2. Mitral annular tissue Doppler pre-ejection and






Pre-ejection wave 5.86 ± 1.69 7.59 ± 2.32 0.001
Ejection wave 7.47 ± 1.59 9.23 ± 2.01 0.001
Data expressed as mean ± standard deviation.Results
The study included 42 consecutive patients with
recent or old myocardial infarction with docu-
mented significant coronary artery disease by
coronary angiography and submitted to elective
percutaneous coronary intervention (18 patients)
or coronary artery bypass grafting surgery with
two or three grafts (24 patients). They all
underwent complete successful revascularization
that included the infarct-related arteries. The
baseline characteristics are detailed in Table 1.
The LVEF at rest was 38.2 ± 9.5% while at 5 ug/
kg/min infusion rate of dobutamine during the
study was 43.2 ± 9.7%. The ejection fraction
improved at one-month follow up after revascu-
larization (38.2 ± 9.5% vs. 44.1 ± 10.3%, p = 0.0001).
There was an excellent correlation between LVEF
during 5 ug/kg/min dobutamine infusion and
LVEF after revascularization (r = 0.93, p < 0.0001).Detection of myocardial viability
Low dose dobutamine echocardiography for
detection of viability was performed on the 42 pa-tients by using TDI. Among the 42 patients, 252
walls were studied. The normokinetic walls at rest
detected by 2D conventional echocardiography
were excluded from the study, so the remaining
diseased walls were 196. Table 2 presents the val-
ues of the pre-ejection and the ejection waves dur-
Figure 2. ROC curve: THE best cut-off value for the change of the
ejection wave at 5 ug/kg/min dobutamine infusion to predict
improvement after revascularization is 1.75 cm/s. AUC = 0.615,
CI = 0.533–0.693, p = 0.01.
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during dobutamine infusion (5 ug/kg/min).
Another two-dimensional and TDI study was
conducted after revascularization at one-month
follow up. Improvement was detected at one-
month post-revascularization in 65 walls out of
the 196 walls (33.16%).
There was good correlation between the pre-
ejection wave at 5 ug/kg/min dobutamine infusion
and the pre-ejection wave after revascularization
(r = 0.64, p = 0.01). There was moderate correlation
between the ejection wave at 5 ug/kg/min dobuta-
mine infusion and the ejection wave after revascu-
larization (r = 0.50, p = 0.01).
Using ROC curves, the optimal cut-off value for
viability assessment was an increase of 1.75 cm/s
in pre-ejection velocity during DSTDE (65% sensi-
tivity, 67% specificity, area under the curve 0.70,
p < 0.001, Fig. 1). On the other hand, the optimal
cut-off value for viability assessment was an in-
crease of 1.75 cm/s in ejection velocity during
DSTDE (58% sensitivity, 63% specificity, area un-
der the curve 0.613, p = 0. 01, Fig. 2).
The diagnostic accuracy of the DSTDE was cal-
culated against the gold standard of viability
(improvement after revascularization). DSTDE
(pre-ejection wave) correctly identified 43 walls
as viable and 89 walls as non-viable. Twenty-two
walls were erroneously classified as non-viable
and 42 walls as viable. Thus, the sensitivity, spec-
ificity, and total accuracy of the DSTDE (pre-ejec-
tion wave) were 66.15%, 67.94%, and 67.35%,
respectively.Figure 1. ROC curve: the best cut-off value for the change of the pre-
ejection wave at 5 ug/kg/min dobutamine infusion to predict
improvement after revascularization is 1.75 cm/s. AUC = 0.700,











DTSE = dobutamine stress tissue Doppler echocardiography, CI = 95%
confidence interval.DSTDE (ejection wave) correctly identified 37
walls as viable and 84 walls as non-viable.
Twenty-eight walls were erroneously classified
as non-viable and 47 walls as viable. Thus, the
sensitivity, specificity, and total accuracy of the
DSTDE (ejection wave) were 56.92%, 64.12%, and
61.43%, respectively (Table 3).Discussion
Assessment of myocardial viability in patients
with myocardial infarction is important. Dobuta-
mine stress echocardiography is widely used in
the clinical setting because it is a safe and accurate
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is its subjective interpretation [4]. TDI, as a
quantitative technique for the assessment of
myocardial velocities, is at least as accurate in
identifying viable myocardium as are traditional
qualitative methods. However, the recording of
myocardial velocities during the dobutamine
stress echo is a time consuming technique [17–
18]. The need to acquire all values on-line within
a limited time margin at peak stress is a limitation
of this modality [18].
Assessment of mitral annular motion velocities
along the long axis with tissue Doppler imaging
has several advantages over regional left ventricu-
lar wall motion velocities, such as the simplicity of
measurement, superior time resolution, and pre-
load independence [13–15]. Various studies have
focused on the relationship between mitral annu-
lar motion and LV systolic function. Specifically, it
has been reported that mitral annular motion
determined with M-mode or two-dimensional
echocardiography correlates with the LVEF in
healthy individuals or in patients with heart
diseases [6,7]. Alam found that the amplitude of
mitral annular motion decreases in infracted re-
gions [7]. In addition, another study reported that
systolic mitral annular motion toward the cardiac
apex measured with M-mode echocardiography
could have a high degree of sensitivity and speci-
ficity for detection of myocardial viability [8]. It
was also found that the correlation between ejec-
tion fraction (EF) and the systolic mitral annular
velocity is relatively good irrespective of the pres-
ence or absence of significant mitral regurgitation.
Measurements of annular velocities constitute a
simple and useful method for evaluating patients
with heart failure [19]. In another study, it was
found that M-mode echocardiography and
pulsed-wave DTI used for assessment of mitral
annular motion are useful methods for evaluation
of LV function. However, parameters measured
by pulsed-wave DTI correlate more strongly with
plasma brain natriuretic peptide levels than
those measured by M-mode echocardiography
and provide a simple, sensitive, accurate and
reproducible tool for early diagnosis of LV dys-
function [20].
Therefore, the main point of this study was that
TDI of the mitral annular motion, as a quantitative
and easy technique for the assessment of myocar-
dial viability, is accurate in identifying viable myo-
cardium in patients with previous myocardial
infarction.
These results coincide with those of an earlier
report which also studied the response of systolicmitral annular motion velocities to dobutamine
infusions and its relation to prediction of myocar-
dial viability. The study included 45 patients with
previous myocardial infarction. A 99mTc-meth-
oxyisobutylisonitrile scintigraphy was performed
to detect viability. This study showed that when
the cut-off value for an increase in pre-systolic
wave was set at 2 cm/s, myocardial viability was
predicted with a sensitivity of 92% and specificity
of 90% [12]. When the cut-off value for an increase
in systolic wave was set at 2 cm/s, myocardial
viability was predicted with a sensitivity of 67%
and specificity of 58% [12].
Another report investigated low dose dobuta-
mine stress echocardiography (LDDSE) combined
with tissue Doppler imaging (TDI) of the myocar-
dial segments for the quantitative assessment of
the content of viable myocardium (defined
according to postoperative recovery) [18]. Conven-
tional qualitative LDDSE showed a sensitivity of
78% and specificity of 85% in predicting myocar-
dial recovery. The optimal cut-off value for viabil-
ity assessment was an increase of 0.5 cm/s in
ejection velocity during LDDSE (80% sensitivity
and 88% specificity, area under the curve 0.801),
0.6 cm/s in pre-ejection velocity (91% sensitivity
and 90% specificity, area under the curve 0.890)
[18].
Penicka et al. [21] assessed the accuracy of tissue
Doppler imaging-derived myocardial positive
pre-ejection velocity (+Vic) in detecting myocar-
dial viability defined by dobutamine stress
echocardiography (DSE), fluorine-18 fluorodeo-
xyglucose positron emission tomography (PET),
contrast-enhanced magnetic resonance imaging
(MRI), and recovery of left ventricular (LV) func-
tion after coronary artery bypass grafting in
patients with chronic ischemic LV dysfunction. A
good agreement was observed between +Vic and
detection of viable myocardium at DSE, PET,
and MRI (kappa = 0.76). The presence of +Vic in
greater than or equal to five dysfunctional seg-
ments had the highest sensitivity (93%) and spec-
ificity (60%) to identify patients (n = 28) with > or
=10% increase in LVEF between baseline and
six-month echocardiogram [21].
Another study tested the ability of pre-ejection
velocity to predict recovery of myocardial contrac-
tile function after coronary revascularization in
acute myocardial infarction. Longitudinal myocar-
dial velocities were recorded at rest by pulsed-
wave TDI echocardiography 6 +/ 2 h after revas-
cularization. They showed a positive pre-ejection
velocity after revascularization predicted recovery
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dial viability was evaluated by TDI, the pre-ejec-
tion wave during early systole showed greater
sensitivity and specificity for the prediction of
myocardial viability than the ejection wave. It
has been reported that endocardial dysfunction
generally occurs during the early stages of ische-
mia, resulting in a predominant impairment of
longitudinal fiber contraction during early systole
[23,24]. Residual viability of longitudinal fibers in
the infarcted region is closely associated with an
increase in pre-ejection wave velocity after dobu-
tamine administration [12]. Moreover, segments
with extensive scar tissue may show an increase
in ejection velocity during dobutamine infusion
due to the tethering effect of adjacent viable myo-
cardium. A possible way to avoid this effect could
be the evaluation of pre-ejection velocity changes.
During that period, the left ventricle does not
change its shape, and the tethering effect is thus
minimized. Furthermore, the effect of cardiac
rotation is lower during the pre-systolic period
than during the ejection period.
The increase in wall thickness that occurs in nor-
mal myocardium after ventricular activation and
before aortic opening corresponds to the brief
pre-ejection velocity. In our study, the pre-ejec-
tion velocity increased during low dose dobuta-
mine infusion. There was good correlation
between the pre-ejection wave at 5ug/kg/min
dobutamine infusion and the pre-ejection wave
after revascularization (r = 0.64, p = 0.01). This
means that viable hibernating myocardium may
contract at rest when both left ventricular pressure
and wall stress are low (e.g. during pre-ejection
phase); however, it cannot sustain the higher load
during ejection. This is consistent with findings
that positive pre-ejection velocity wave is a sign
of non-transmural necrosis [25] and that increased
segmental systolic velocity during low dose DSE is
associated with viability of these segments [26].
Therefore, the pre-ejection wave more sensi-
tively reflects myocardial viability than the
ejection wave and gives important information
for the detection of reversible myocardial dysfunc-
tion (hibernation) with low dose dobutamine
stress. Furthermore, because pulsed TDI facili-
tates the evaluation of myocardial viability along
the long axis, measurements are relatively easier
to evaluate than measurements along the short
axis, and are minimally influenced by whole heart
motion. To the best of our knowledge, our study is
the first study to predict myocardial viability,
defined by improvement after revascularization,
with pre-ejection mitral annular velocity duringdobutamine stress tissue Doppler echocardiog-
raphy.
Currently, the most cost-effective imaging tech-
niques to detect reversible contractile function are
stress echocardiography and nuclear perfusion
imaging [1,2]. Echocardiography has the advan-
tage of widespread availability, but subjective
evaluation remains its main limitation [4]. TDI
provides quantitative data; however, the record-
ing of myocardial velocities during dobutamine
stress echo is a time consuming technique [18].
Therefore, recording of mitral annular TDI veloci-
ties is relatively simple and should be technically
feasible for evaluation of regional myocardial via-
bility in patients with myocardial infarction.
Limitations of the study
We arbitrarily timed the outcome of dysfunc-
tional segment 1 month after revascularization to
avoid the interaction of possible restenosis on
functional recovery. However, potential functional
improvement after this time cannot be ruled out.
Accurate definition of culprit artery restenosis
could have been done with another follow-up
angiography, but that would have increased the
cost of the study. Pulsed TDI was performed at
the level of the mitral annulus, but the regional
myocardium itself was not evaluated. Therefore,
measured values might be influenced by the in-
farcted area or wall motion in the non-infarcted
regions. Moreover, left atrial hemodynamics
might influence mitral annular motion in patients
with markedly elevated LV end diastolic pressure
or left atrial dilatation. It was not possible to assess
the ability of TDI to optimize prediction of death-
free outcome in long-term follow-up.
Conclusion and recommendations
Viable left ventricular myocardium could be
identified quantitatively and easily with peak
pre-ejection mitral annular velocity during dobu-
tamine stress tissue Doppler echocardiography.
The pre-ejection wave during early systole
showed greater sensitivity and specificity for the
prediction of myocardial viability than the ejection
wave. In view of the small sample size included in
this report, larger clinical studies are needed to
confirm these observations.
Appendix A. Supplementary data
Supplementary data associated with this article
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